Paper41233335
Depressive symptomatology in the first-episode schizophrenia spectrum disorders OPTiMiSE trial: prevalence, correlates, symptom progression and outcomes.
Lopez-Morinigo JD and 8 others. Schizophrenia (Heidelb), 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Depressive symptomatology in the first-episode schizophrenia spectrum disorders OPTiMiSE trial: prevalence, correlates, symptom progression and outcomes. Papers, record 41233335. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41233335
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Depressive symptomatology in the first-episode schizophrenia spectrum disorders OPTiMiSE trial: prevalence, correlates, symptom progression and outcomes.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants8
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| HEALTH-F2-2010-242114 | European Commission (EC) | PubMed | ||
| HEALTH-F2-2010-242114 | European Commission (EC) | PubMed | ||
| HEALTH-F2-2010-242114 | European Commission (EC) | PubMed | ||
| HEALTH-F2-2010-242114 | European Commission (EC) | PubMed | ||
| HEALTH-F2-2010-242114 | European Commission (EC) | PubMed | ||
| HEALTH-F2-2010-242114 | European Commission (EC) | PubMed | ||
| HEALTH-F2-2010-242114 | European Commission (EC) | PubMed | ||
| HEALTH-F2-2010-242114 | European Commission (EC) | PubMed |
Source PubMed
References77
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11102326 | Cognitive approach to depression and suicidal thinking in psychosis. 1. Ontogeny of post-psychotic depression. | Br J Psychiatry | 2000 | https://conductscience.org/library/papers/11102326 | PubMed |
| 2 | 38691387 | Efficacy and Safety of Xanomeline-Trospium Chloride in Schizophrenia: A Randomized Clinical Trial. | JAMA Psychiatry | 2024 | https://conductscience.org/library/papers/38691387 | PubMed |
| 3 | 33069317 | Amisulpride, aripiprazole, and olanzapine in patients with schizophrenia-spectrum disorders (BeSt InTro): a pragmatic, rater-blind, semi-randomised trial. | Lancet Psychiatry | 2020 | https://conductscience.org/library/papers/33069317 | PubMed |
| 4 | 40268731 | Mental health status of the European population and its determinants: A cross-national comparison study. | Eur Psychiatry | 2025 | https://conductscience.org/library/papers/40268731 | PubMed |
| 5 | 10782554 | Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social functioning. | Acta Psychiatr Scand | 2000 | https://conductscience.org/library/papers/10782554 | PubMed |
| 6 | 21568628 | Depressive symptoms and their association with acute treatment outcome in first-episode schizophrenia patients: comparing treatment with risperidone and haloperidol. | World J Biol Psychiatry | 2012 | https://conductscience.org/library/papers/21568628 | PubMed |
| 7 | 19922525 | The evolution of depression and suicidality in first episode psychosis. | Acta Psychiatr Scand | 2010 | https://conductscience.org/library/papers/19922525 | PubMed |
| 8 | 34942142 | The neuropsychiatry of Parkinson's disease: advances and challenges. | Lancet Neurol | 2022 | https://conductscience.org/library/papers/34942142 | PubMed |
| 9 | 29431197 | Efficacy and safety of antidepressant augmentation of continued antipsychotic treatment in patients with schizophrenia. | Acta Psychiatr Scand | 2018 | https://conductscience.org/library/papers/29431197 | PubMed |
| 10 | 2278986 | A depression rating scale for schizophrenics. | Schizophr Res | 1990 | https://conductscience.org/library/papers/2278986 | PubMed |
| 11 | 35546936 | Depressive Symptoms and PANSS Symptom Dimensions in Patients With Predominant Negative Symptom Schizophrenia: A Network Analysis. | Front Psychiatry | 2022 | https://conductscience.org/library/papers/35546936 | PubMed |
| 12 | 9881538 | The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. | J Clin Psychiatry | 1998 | https://conductscience.org/library/papers/9881538 | PubMed |
| 13 | 16005381 | Schizophrenia and depression: challenging the paradigm of two separate diseases--a controlled study of schizophrenia, depression and healthy controls. | Schizophr Res | 2005 | https://conductscience.org/library/papers/16005381 | PubMed |
| 14 | 30115598 | Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study. | Lancet Psychiatry | 2018 | https://conductscience.org/library/papers/30115598 | PubMed |
| 15 | 8866775 | A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables. | Int Clin Psychopharmacol | 1995 | https://conductscience.org/library/papers/8866775 | PubMed |
| 16 | 20118450 | The Kraepelinian dichotomy - going, going... but still not gone. | Br J Psychiatry | 2010 | https://conductscience.org/library/papers/20118450 | PubMed |
| 17 | 27421793 | Depression and Schizophrenia: Cause, Consequence, or Trans-diagnostic Issue? | Schizophr Bull | 2017 | https://conductscience.org/library/papers/27421793 | PubMed |
| 18 | 22627166 | Treatment of depression in first episode of schizophrenia: results from EUFEST. | Eur Neuropsychopharmacol | 2012 | https://conductscience.org/library/papers/22627166 | PubMed |
| 19 | 33271709 | Depression in schizophrenia: Prevalence and its impact on quality of life, disability, and functioning. | Asian J Psychiatr | 2020 | https://conductscience.org/library/papers/33271709 | PubMed |
| 20 | 31964558 | Depressive symptoms during first episode psychosis and functional outcome: A systematic review and meta-analysis. | Schizophr Res | 2020 | https://conductscience.org/library/papers/31964558 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42169702 | Changes in insight and outcome over the early course of first-episode psychosis. The OPTiMiSE trial. | Schizophr Res Cogn | 2026 | https://conductscience.org/library/papers/42169702 | PubMed |
| 41712510 | Identifying Transdiagnostic Predictors of Depression across Psychoses: Informing Stratified Antidepressant Treatments. | Psychother Psychosom | 2026 | https://conductscience.org/library/papers/41712510 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41233335
GET https://conductscience.org/api/papers/v1/41233335/references?page=2